Effect Of Cyclophosphamide Treatment On Central And Effector Memory T Cells In Mice

Immunological memory is a key feature of adaptive immunity. It provides the organism with long-lived and robust protection against infection. The important question is whether cyclophosphamide (CP), as immunosuppressive agent used in cancer therapy and in some autoimmune diseases, may act on the memory T-cell population. We investigated the effect of CP on the percentage of central memory T cells (T-CM) and effector memory T cells (T-EM) in the mouse model of CP-induced immunosuppression (8-10-week-old male C57BL/6 mice CP treated for 7 days at the daily dose of 50 g/g body weight [bw], manifested the best immunosuppression status, as compared to lower doses of CP: 10 or 20 g/g bw). The CP induced a significant decrease in the percentage of CD8(+) (T-CM), compared to nonimmunosuppressed mice. This effect was not observed in the case of CD4(+) T-CM population. The percentage of gated T-EM with CD4 and CD8 phenotype was significantly decreased in CP-treated mice, as compared to the control ones. Taken together, the above data indicate that CP-induced immunosuppression in mice leads to a reduction in the abundance of central memory cells possessing preferentially CD8(+) phenotype as well as to a reduction in the percentage of effector memory cells (splenocytes both CD4(+) and CD8(+)), compared to the cells from nonimmunosuppressed mice. These findings in mice described in this article may contribute to the understanding of the complexity of the immunological responses in humans and extend research on the impact of the CP model of immunosuppression in mice and memory T-cell populations.